Gufic BioSciences Ltd Performance
Day's Low
Day's High
₹396.2₹421.752 Week's Low
52 Week's High
₹277.65₹504.25
| Returns % | |
| 1 Month Return | -6.01 % |
| 3 Month Return | + 16.04 % |
| 1 Year Return | + 42.36 % |
| Market Stats | |
| Previous Close | ₹423.10 |
| Open | ₹421.70 |
| Volume | 63.62K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹4,242.74Cr |
Gufic BioSciences Ltd Key Statistics
| P/E Ratio | 49.89 |
| PEG Ratio | 12.6 |
| Market Cap | ₹4,242.74 Cr |
| P/B Ratio | 5.33 |
| EPS | 0 |
| Dividend Yield | 0.04 |
| Sector | Pharmaceuticals |
| ROE | 19.57 |
Gufic BioSciences Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹4,242.74 Cr | 105.92% | 0.70 | ₹86 Cr | ₹806 Cr | |
| NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
| NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
| NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
| NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Gufic BioSciences Ltd Mutual Fund Holdings
About Gufic BioSciences Ltd
Share Price: ₹405.60 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹4,242.74Cr as of today
Revenue: ₹204.18Cr as on September 2024 (Q3 24)
Net Profit: ₹21.77Cr as on September 2024 (Q3 24)
Listing date: 19 Oct, 2004
Chairperson Name: Jayesh P Choksi
| Organisation | Gufic BioSciences Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Gufic BioSciences Ltd
Gufic Biosciences Reports Decline in Q2 Profit - 18 Nov, 2024
Gufic Biosciences' Q2 FY25 net profit fell 6.03% YoY to Rs 21.8 crore, with revenue down 4.98%. Despite a decrease in total expenses, the stock tumbled 5.87%. EBITDA also declined by 2.52%.
Gufic Biosciences Reports Decline in Q2 Profit - 15 Nov, 2024
Gufic Biosciences reported a 6% year-on-year drop in Q2 net profit to Rs 21.8 crore, alongside a 4.98% decline in revenue. Despite a decrease in total expenses, EBITDA fell by 2.52%, though the EBITDA margin improved slightly.
Insights on Gufic BioSciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 2.30% to 2.51% in Sep 2024 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.23% to 0.24% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 1.4%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 16.2%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.51% of holdings in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 24.88% to 24.74% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, GUFICBIO stock has moved down by -5.0%
Gufic BioSciences Ltd Financials
Index Inclusions
Gufic BioSciences Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 72.51% | 0.00 | |
| Foreign Institutions | 0.24% | 2.75 | |
| Mutual Funds | 2.51% | 9.23 | |
| Retail Investors | 24.74% | ||
| Others | 0% |
Gufic BioSciences Ltd Key Indicators
Gufic BioSciences Ltd Valuation
Gufic BioSciences Ltd in the last 5 years
Lowest (0.00x)
March 28, 2024
Today (49.89x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (57.25x)
November 8, 2024
Gufic BioSciences Ltd Earnings and Dividends
Gufic BioSciences Ltd Earnings Results
Gufic BioSciences Ltd’s net profit fell -6.2% since last year same period to ₹21.77Cr in the Q2 2024-2025. On a quarterly growth basis, Gufic BioSciences Ltd has generated 4.36% jump in its net profits since last 3-months.
Read More about Earnings ResultsGufic BioSciences Ltd Dividends May,2024
In the quarter ending March 2024, Gufic BioSciences Ltd has declared dividend of ₹0.10 - translating a dividend yield of 0.05%.
Read More about Dividends
Gufic BioSciences Ltd Technicals Summary
Bearish
Neutral
Bullish
Gufic BioSciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Gufic BioSciences Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Gufic BioSciences Ltd shares.
Gufic BioSciences Ltd (GUFICBIO) share price today is ₹405.6
Gufic BioSciences Ltd is listed on NSE
Gufic BioSciences Ltd is listed on BSE
- Today’s highest price of Gufic BioSciences Ltd is ₹421.7.
- Today’s lowest price of Gufic BioSciences Ltd is ₹396.2.
PE Ratio of Gufic BioSciences Ltd is 49.89
PE ratio = Gufic BioSciences Ltd Market price per share / Gufic BioSciences Ltd Earnings per share
Today’s traded volume of Gufic BioSciences Ltd(GUFICBIO) is 63.62K.
Today’s market capitalisation of Gufic BioSciences Ltd(GUFICBIO) is ₹4242.74Cr.
| Gufic BioSciences Ltd(GUFICBIO | Price |
|---|---|
52 Week High | ₹504.25 |
52 Week Low | ₹277.65 |
Gufic BioSciences Ltd(GUFICBIO) share price is ₹405.6. It is down -19.56% from its 52 Week High price of ₹504.25
Gufic BioSciences Ltd(GUFICBIO) share price is ₹405.6. It is up 46.08% from its 52 Week Low price of ₹277.65
| Gufic BioSciences Ltd(GUFICBIO | Returns |
|---|---|
1 Day Returns | -17.5% |
1 Month Returns | -6.01% |
3 Month Returns | 16.04% |
1 Year Returns | 42.36% |